Published in Biochim Biophys Acta on December 10, 1968
On the association between transmitter secretion and the release of adenine nucleotides from mammalian motor nerve terminals. J Physiol (1975) 2.56
Release of adenosine triphosphate from isolated adult heart cells in response to hypoxia. J Physiol (1977) 1.37
A possible role for nucleoside-protein complexes in membrane. Br J Pharmacol (1971) 0.83
Colorimetric Estimation of Succinic Dehydrogenase by Triphenyltetrazolium Chloride. Science (1949) 4.77
Donor cell-derived acute myeloid leukemia after unrelated umbilical cord blood transplantation. Leukemia (2006) 1.77
Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene (2010) 1.68
Myelofibrosis and systemic lupus erythematosus: reversal of fibrosis with high-dose corticosteroid therapy. Acta Haematol (1992) 1.48
Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells. Cancer Res (1997) 1.48
Expression of the P2X(2) receptor subunit of the ATP-gated ion channel in the cochlea: implications for sound transduction and auditory neurotransmission. J Neurosci (1999) 1.40
Influence of sulfhydryl reagents and heavy metals on the functional state of the muscarinic acetylcholine receptor in rat brain. Mol Pharmacol (1978) 1.33
Differential localization of delta glutamate receptors in the rat cerebellum: coexpression with AMPA receptors in parallel fiber-spine synapses and absence from climbing fiber-spine synapses. J Neurosci (1997) 1.29
The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol (2002) 1.14
Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms. Br J Cancer (2013) 1.11
Cloning and functional expression of human endothelin-converting enzyme cDNA. Biochem Biophys Res Commun (1995) 1.09
The arrangement of glutamate receptors in excitatory synapses. Ann N Y Acad Sci (1999) 1.07
Molecular organization of a type of peripheral glutamate synapse: the afferent synapses of hair cells in the inner ear. Prog Neurobiol (1998) 1.06
Purification of the opiate receptor from rat brain. Proc Natl Acad Sci U S A (1981) 1.04
Electrophysiological, behavioral, and chemical evidence for a noncholinergic, stereospecific site for nicotine in rat brain. J Neurosci Res (1978) 1.03
Solubilization of the opiate receptor. Life Sci (1980) 1.00
Select types of supporting cell in the inner ear express aquaporin-4 water channel protein. Eur J Neurosci (1998) 0.98
A nonsense mutation of IDH1 in myelodysplastic syndromes and related disorders. Leukemia (2010) 0.95
Cocaine and phencyclidine inhibition of the acetylcholine receptor: analysis of the mechanisms of action based on measurements of ion flux in the millisecond-to-minute time region. Proc Natl Acad Sci U S A (1982) 0.95
Discrete cellular and subcellular localization of glutamine synthetase and the glutamate transporter GLAST in the rat vestibular end organ. Neuroscience (1997) 0.94
Stereoselective muscarinic acetylcholine and opiate receptiors in human phagocytic leukocytes. Biochem Pharmacol (1980) 0.93
Interrelationships between phosphates and calcium in bioelectric phenomena. Int Rev Neurobiol (1966) 0.93
Sites and mechanisms for nicotine's action in the brain. Neurosci Biobehav Rev (1981) 0.93
Biochemical analysis of isolated bullfrog sarcolemma. Biochim Biophys Acta (1966) 0.91
Conversion between configurational states of the muscarinic receptor in rat brain. Eur J Pharmacol (1977) 0.91
Cocaine: mechanism of inhibition of a muscle acetylcholine receptor studied by a laser-pulse photolysis technique. Proc Natl Acad Sci U S A (1995) 0.90
Stimulation of phospholipase A2 and secretion of catecholamines from brain synaptosomes by potassium and A23187. J Neurochem (1983) 0.89
Relationship between the localization of fibroblast growth factor 9 in prostate cancer cells and postoperative recurrence. Prostate Cancer Prostatic Dis (2011) 0.89
Positive and negative transcriptional regulation by the yeast GAL11 protein depends on the structure of the promoter and a combination of cis elements. Mol Gen Genet (1994) 0.87
Relationship of calcium and phosphates to bioelectric phenomena in the excitatory membrane. Perspect Biol Med (1965) 0.87
Development of small hepatocellular carcinoma 80 months after clearance of hepatitis C virus with interferon therapy. Eur J Gastroenterol Hepatol (2000) 0.85
Immunocytochemistry of receptors using anti-idiotypic antibodies. Methods Enzymol (1989) 0.85
Immunocytochemical localization of intermediate filaments in the guinea pig vestibular periphery with special reference to their alteration after ototoxic drug administration. Acta Otolaryngol Suppl (1993) 0.85
Development of muscarinic cholinergic receptors in inbred strains of mice: identification of receptor heterogeneity and relation to audiogenic seizure susceptibility. Brain Res (1979) 0.84
Muscarinic cholinergic binding in human erythrocyte membranes. Life Sci (1977) 0.84
The localization of proteins encoded by CRYM, KIAA1199, UBA52, COL9A3, and COL9A1, genes highly expressed in the cochlea. Neuroscience (2008) 0.84
Stereospecific 3H-nicotine binding to intact and solubilized rat brain membranes and evidence for its noncholinergic nature. Life Sci (1980) 0.83
Fluidity in hydrophobic protein regions of synaptic membranes. Eur J Biochem (1974) 0.82
Uptake and biliary excretion of Cu64 in rabbits in relation to blood ceruloplasmin. Proc Soc Exp Biol Med (1965) 0.82
Preparation and characterization of calcium-binding and other hydrophobic proteins from synaptic membranes. Biochim Biophys Acta (1976) 0.82
NMDA (NMDAR1) and AMPA-type (GluR2/3) receptor subunits are expressed in the inner ear. Neuroreport (1995) 0.81
Preparation and spectroscopic characterization of molecular species of brain phosphatidylserines. Chem Phys Lipids (1980) 0.81
Early elevations of glycosidase, acid phosphatase, and acid proteolytic enzyme activity in denervated skeletal muscle. Exp Neurol (1974) 0.81
In vivo incorporation of l-[14C]serine into phospholipids and proteins of the subcellular fractions of developing rat brain. J Neurochem (1966) 0.81
Inhibitory effect of orally administered aldose reductase inhibitor SNK-860 on corneal polyol accumulation in galactose-fed rats. Graefes Arch Clin Exp Ophthalmol (1999) 0.81
Effect of an aldose reductase inhibitor, SNK-860, on deficits in the electroretinogram of diabetic rats. Exp Physiol (1995) 0.80
[3H]methylcarbamylcholine, a new radioligand for studying brain nicotinic receptors. Biochem Pharmacol (1986) 0.80
Carbamate ester latentiation of physiologically active amines. J Med Chem (1970) 0.79
Stereospecific morphine adsorption to phosphatidyl serine and other membranous components of brain. Eur J Pharmacol (1975) 0.79
HepG2/erythrocyte glucose transporter (GLUT1) gene in NIDDM: a population association study and molecular scanning in Japanese subjects. Diabetologia (1995) 0.79
Separation of brain phosphatidylserines according to degree of unsaturation by thin-layer chromatography. Anal Biochem (1976) 0.79
Various glutathione S-transferase isoforms in the rat cochlea. Neuroreport (2001) 0.79
Isolation of a nicotine binding site from rat brain by affinity chromatography. Proc Natl Acad Sci U S A (1983) 0.79
Phospholipid changes in synaptic membranes by lipolytic enzymes and subsequent restoration of opiate binding with phosphatidylserine. Biochim Biophys Acta (1978) 0.78
Biochemical studies on isolated nerve endings and other particulates of bullfrog brain. Biochim Biophys Acta (1967) 0.78
Antagonism of nicotine's action by cocaine analogs. Life Sci (1995) 0.78
Enhancement of stereospecific opiate binding to neural membranes by phosphatidyl serine. Eur J Pharmacol (1976) 0.78
Barrel rotation and prostration by vasopressin and nicotine in the vestibular cerebellum. Pharmacol Biochem Behav (1986) 0.78
[3H]mecamylamine binding to rat brain membranes. Studies with mecamylamine and nicotine analogues. Biochem Pharmacol (1990) 0.78
Expression and characterization of the rat alpha 4 beta 2 neuronal nicotinic cholinergic receptor in baculovirus-infected insect cells. J Neurosci Res (1996) 0.78
14 beta-(2-bromoacetamido)morphine and 14 beta-(2-bromoacetamido)morphinone. J Med Chem (1983) 0.77
Immunocytochemical localization of substance P and neurofilament proteins in the guinea pig vestibular ganglion. Acta Otolaryngol Suppl (1993) 0.77
Opioid receptor antagonist affinity ligands: 6 beta-bromoacetamido-6-desoxynaltrexone and 6 beta-thioglycolamido-6-desoxynaltrexone. Neurochem Res (1992) 0.77
Neurotransmission in the vestibular endorgans--glutamatergic transmission in the afferent synapses of hair cells. Biol Sci Space (2001) 0.77
Phosphate activated glutaminase is concentrated in mitochondria of sensory hair cells in rat inner ear: a high resolution immunogold study. J Neurocytol (1999) 0.77
Evidence for a noncholinergic site for nicotine's action in brain: psychopharmacological, electrophysiological and receptor binding studies. Arch Int Pharmacodyn Ther (1979) 0.77
Successful treatment of acquired pure red cell aplasia and acquired amegakaryocytic thrombocytopenia with anti-thymocyte globulin. Am J Hematol (2001) 0.77
Two classes of arginine vasopressin binding sites on rat brain membranes. Neurochem Res (1985) 0.77
Differential effect of sodium and potassium on calcium adsorption to stearic acid monolayers. Biochim Biophys Acta (1968) 0.77
Behavior and receptor changes after kainate lesioning of nodular cerebellum. Pharmacol Biochem Behav (1986) 0.76
Localization of substance P-like immunoreactivity in guinea pig vestibular endorgans and the vestibular ganglion. Brain Res (1991) 0.76
Nicotine antagonists: phosphoinositide turnover and receptor binding to determine muscarinic properties. Biochem Pharmacol (1989) 0.76
Sporadic isolations of a multi-drug resistant Pseudomonas aeruginosa clone during a 14-month epidemic in a general hospital in Hiroshima. Infection (2011) 0.76
Limitations of ureteroscopy in diagnosis of invasive upper tract urothelial cancer. Urol Int (1996) 0.76
Determination of monosaccharides and sugar alcohols in tissues from diabetic rats by high-performance liquid chromatography with pulsed amperometric detection. Anal Biochem (1992) 0.76
Mechanism of phospholipase A2-induced conduction block in bullfrog sciatic nerve. II. Biochemistry. Brain Res (1986) 0.76
A human pancreatic islet inwardly rectifying potassium channel: cDNA cloning, determination of the genomic structure and genetic variations in Japanese NIDDM patients. Diabetologia (1996) 0.75
Characterization of a purified nicotinic receptor from rat brain by using idiotypic and anti-idiotypic antibodies. Proc Natl Acad Sci U S A (1987) 0.75
Chemical requirements of vasopressins for barrel rotation convulsions and reversal by oxytocin. J Neurosci Res (1980) 0.75
Synthesis and biological characterization of pyridohomotropanes. Structure-activity relationships of conformationally restricted nicotinoids. J Med Chem (1988) 0.75
Antagonism by cholinergic drugs of behavioural effects in cats of an anticholinergic psychotomimetic drug and enhancement by nicotine. Neuropharmacology (1977) 0.75
Probing ion channels and recognition sites of neuronal nicotinic cholinergic receptors with novel nicotine affinity and other ligands. Ann N Y Acad Sci (1995) 0.75
4-Bromoacetamidoprocaine: an affinity ligand for brain muscarinic and nicotinic cholinergic receptors. Neurochem Res (1992) 0.75
Synthesis of the first highly potent bridged nicotinoid 9-Azabicyclo[4.2.1]nona[2,3-c]pyridine (pyrido[3,4-b]homotropane). J Am Chem Soc (1986) 0.75
Acute and chronic effects of nicotine in rats and evidence for a noncholinergic site of action. NIDA Res Monogr (1979) 0.75
Differences in ligand binding and phosphoinositide turnover between M1 muscarinic receptor gene transfected cells and mouse and rat brain membranes. Pharmacol Biochem Behav (1994) 0.75
Phospholipid involvement in the interaction of abused drugs with neural membranes. Prog Clin Biol Res (1979) 0.75
Arginine vasopressin-anti-idiotypic immunostaining of human brain cells. J Neuroendocrinol (1990) 0.75
Receptor binding characteristics of a 3H-labeled azetidine analogue of nicotine. Biochem Pharmacol (1987) 0.75
Enhancement of opiate binding to neural membranes with an ethyl glycolate ester of phosphatidyl serine. Neurochem Res (1977) 0.75
Solubilization and purification of the Ni-stimulated arginine-vasopressin binding site of rat brain membranes. Neurochem Res (1987) 0.75
Coherent precession of magnetization in the superfluid 3He A-phase. Phys Rev Lett (2008) 0.75
Structure-activity relationships for various N-alkylcarbamyl esters of choline with selective nicotinic cholinergic properties. Biochem Pharmacol (1991) 0.75
Membrane mechanisms of drugs of abuse. A review of the conference. Prog Clin Biol Res (1979) 0.75
5-Isothiocyanonicotine: a high-affinity irreversible ligand for brain nicotinic receptors. Biochem Pharmacol (1994) 0.75
Differential desensitization of muscarinic receptor-stimulated phosphoinositide turnover in the rat brain. Neurochem Int (1990) 0.75
Inhibition of phosphoinositide turnover by selective muscarinic antagonists in the rat striatum. Correlation with receptor occupancy. Biochem Pharmacol (1988) 0.75
Effects of the affinity ligands 14-beta-chloroacetylnaltrexone and 14-beta-bromoacetamidomorphine on [3H]-dihydromorphine binding sites in rat brain. Biochem Pharmacol (1986) 0.75